BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Macquarie maintains outperform on Strides Arcolab
Expect Strides Arcolab to launch Sovaldi Generic (a medicine used to treat hepatitis C virus) in India in the second quarter of 2015-16. Valuations look attractive at 13-times FY17 price earnings ratio. Target raised to Rs 1550 from Rs 1260.